Imaging of lysophosphatidylcholine in human coronary plaques by color fluorescence angioscopy

International Heart Journal

Volumn 51, Issue 2, 2010, Pages 129-133

  Uchida, Yasumi ^a,b,c,d   Uchida, Yasuto ^e   Kawai, Seiji ^d   Kanamaru, Ryohei ^d   Kameda, Noriaki ^c  

^a The Japan Foundation   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^d Chiba kensei Hospital   (Japan)

^e TOHO UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Color fluorescence angioscopy; Coronary plaque; Lysophosphatidylcholine; Trypan blue dye

Indexed keywords

DYE; LYSOPHOSPHATIDYLCHOLINE; TRYPTAN BLUE DYE; UNCLASSIFIED DRUG;

ADULT; ANGIOSCOPY; ARTICLE; ATHEROSCLEROTIC PLAQUE; COLOR FLUORESCENCE ANGIOSCOPY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; FILTRATION; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGING SYSTEM; IN VITRO STUDY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL;

AGED; ANGIOSCOPES; ANGIOSCOPY; COLORING AGENTS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; TISSUE CULTURE TECHNIQUES; TRYPAN BLUE;

EID: 77951469757     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.51.129     Document Type: Article

References (24)

1. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74. (Review)
2. Aiyar N, Disa J, Ao Z, et al. Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells. Mol Cell Biochem 2007; 295: 113-20.
3. Virani SS, Nambi V. The role of lipoprotein-associated phos-pholipase A2 as a marker of atherosclerosis. Curr Atheroscler Rep 2007; 9: 97-103. (Review)
4. Erdogan A, Schaefer MB, Kulmann CR, et al. Activation of Ca2+ -activated potassium channels is involved in lysophos-phatidylcholine-induced monocyte adhesion to endothelial cells. Atherosclerosis 2007; 190: 100-5.
5. Matsubara M, Hasegawa K. Benidipine, a dihydropyridine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells. Atherosclerosis 2005; 178: 57-66.
6. Kougias P, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 2006; 12: RA5-16. (Review)
7. Matsumoto T, Kobayashi T, Kamata K. Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem 2007; 14: 3209-20. (Review)
8. Messner MC, Albert CJ, McHowat J, Ford DA. Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions. Lipids 2008; 43: 243-9.
9. Lavi S, McConnell JP, Rihal CS, et al. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 2007; 115: 2715-21.
10. Di Mario C, Gorge G, Peters R, et al. Clinical application and image interpretation in intracoronary ultrasound. Study Group on Intracoronary Imaging of the Working Group of Coronary Circulation and of the Subgroup on Intravascular Ultrasound of the Working Group of Echocardiography of the European Society of Cardiology. Eur Heart J 1998; 19: 207-29. (Review)
11. Jang IK, Teamey GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005; 111: 1551-5.
12. Uchida Y, Tomaru T, Nakamura F, Furuse A, Fujimori Y., Hasegawa K. Percutaneous coronary angioscopy in patients with ischemic heart disease. Am Heart J 1987; 114: 1216-22.
13. den Heijer P, Foley DP, Hillege HL, et al. The 'Ermenonville' classification of observations at coronary angioscopy-evaluation of intra- and inter-observer agreement. European Working Group on Coronary Angioscopy. Eur Heart J 1994; 15: 815-22.
14. de Feyter PJ, Ozaki Y, Baptista J, et al. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation 1995; 92: 1408-13.
15. Uchida Y Angioscopic detection of vulnerable coronary plaques and prediction of acute coronary syndromes. In: The Vulnerable Atherosclerotic Plaques. Fuster V (ed). Futura Publishing Co. Armonk, NY; 1999: 111-29.
16. Silveira L Jr, Sathaiah S, Zangaro RA, Pacheco MT, Chavantes MC, Pasqualucci CA. Correlation between near-infrared Raman spectroscopy and the histopathological analysis of atherosclerosis in human coronary arteries. Lasers Surg Med 2002: 30: 290-7.
17. Romer TJ, Brennan JF 3rd, Fitzmaurice M, et al. Histopathology of human coronary atherosclerosis by quantifying its chemical composition with Raman spectroscopy. Circulation 1998;97:878-85.
18. Ralph P, Nakoinz I. Environmental and chemical dissociation of antibody-dependent phagocytosis from lysis mediated by macrophages: stimulation of lysis by sulfhydryl-blocking and esterase-inhibiting agents and depression by trypan blue and trypsin. Cell Immunol 1980; 50: 94-105.
19. Brooks BO, Reed ND. The effect of trypan blue on the early control of Trypanosoma musculi parasitemia in mice. J Reticu-loendothel Soc 1979; 25: 325-8.
20. Yamada N. Molecular mechanisms of diabetic atherosclerosis. Nippon Rinsho 2002; 60: 87-94. (Review) (Japanese)
21. Uchida Y. Coronary Angioscopy. Futura Publishing Co, Armonk, NY; 2001: 41-80.
22. Uchida Y. Coronary angioscopy. In: Cardioangioscopy Uchida Y, ed. Medical View Co., Tokyo; 1995: 46-9.
23. Uchida Y. Visualization of vulnerable coronary plaques by color fluorescence angioscopy system. Circ J 2006; 70: 336.
24. Uchida Y. Detection of vulnerable coronary plaques by color fluorescence angioscopy system: a new technology. Circ J 2009; 73: 491.